Results by group24

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 24

Outcome	Group	Category	Value	Spread	Units
Any Hospitalization or Any Emergency Room Visits	Control Arm	Any ED Visit During Study	497		Participants
Any Hospitalization or Any Emergency Room Visits	Intervention Arm	Any ED Visit During Study	574		Participants
Any Hospitalization or Any Emergency Room Visits	Control Arm	Any Inpatient stay During Study	380		Participants
Any Hospitalization or Any Emergency Room Visits	Intervention Arm	Any Inpatient stay During Study	391		Participants
Total Estimated Health Care Costs, Compared Between the Intervention and Control Groups	Control Arm	Inpatient costs	37,505	Inter-Quartile Range 16,797 to 81,891	dollars
Total Estimated Health Care Costs, Compared Between the Intervention and Control Groups	Intervention Arm	Inpatient costs	56,600	Inter-Quartile Range 22,417 to 108,634	dollars
Total Estimated Health Care Costs, Compared Between the Intervention and Control Groups	Control Arm	Outpatient costs	17,077	Inter-Quartile Range 6,473 to 38,164	dollars
Total Estimated Health Care Costs, Compared Between the Intervention and Control Groups	Intervention Arm	Outpatient costs	25,560	Inter-Quartile Range 10,388 to 51,971	dollars
Total Estimated Health Care Costs, Compared Between the Intervention and Control Groups	Control Arm	Pharmacy costs	10,306	Inter-Quartile Range 4,534 to 19,869	dollars
Total Estimated Health Care Costs, Compared Between the Intervention and Control Groups	Intervention Arm	Pharmacy costs	10,555	Inter-Quartile Range 5,374 to 20,485	dollars
Total Estimated Health Care Costs, Compared Between the Intervention and Control Groups	Control Arm	Total costs	36,255	Inter-Quartile Range 15,672 to 80,508	dollars
Total Estimated Health Care Costs, Compared Between the Intervention and Control Groups	Intervention Arm	Total costs	51,811	Inter-Quartile Range 21,967 to 133,045	dollars
Number of Participants With Graft Survival	Control Arm		864		Participants
Number of Participants With Graft Survival	Intervention Arm		1255		Participants
Patient Survival- Percentage of Patients That Died During Study	Control Arm		144		Participants
Patient Survival- Percentage of Patients That Died During Study	Intervention Arm		195		Participants
Medication Safety Issues	Intervention Arm	Percent of patient with missing labs	733		Participants
Medication Safety Issues	Intervention Arm	Percent of patients alarming lab values without follow up scheduled	760		Participants
Medication Safety Issues	Intervention Arm	Immunosuppression adherence, estimated using the proportion of days covered (PDC) <80%	756		Participants
Medication Safety Issues	Intervention Arm	Percent of patients with hospital discharge or ED visit without follow up scheduled	196		Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03860818/results

API reference For AI assistants

Results by group24

Sources 3

Read this list from software.